Literature DB >> 23009394

Fragile X-associated tremor/ataxia syndrome (FXTAS) in grey zone carriers.

Y Liu1, T I Winarni, L Zhang, F Tassone, R J Hagerman.   

Abstract

The grey zone (GZ; 45-54 CGG repeats in the FMR1 gene) is considered a normal allele; however, several studies have found a high frequency of GZ in movement disordered populations. Here, we describe neurological features of fragile X-associated tremor/ataxia syndrome (FXTAS) in two carriers of GZ alleles, although FXTAS has been defined as occurring only in premutation carriers (55-200 CGG repeats). Both patients had family members who had premutation and were diagnosed with FXTAS. The presence of relatively high GZ alleles with elevated fragile X mental retardation 1 mRNA (FMR1-mRNA) combined with a family history of FXTAS that may represent a facilitating genetic background for FXTAS are the factors that led to the presence of FXTAS in these individuals with a GZ allele. Further research into clinical involvement of GZ alleles is recommended and the definition of FXTAS may require revision.
© 2012 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23009394      PMCID: PMC4991824          DOI: 10.1111/cge.12026

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  15 in total

1.  Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers.

Authors:  Deborah Hall; Flora Tassone; Olga Klepitskaya; Maureen Leehey
Journal:  Mov Disord       Date:  2011-12-11       Impact factor: 10.338

2.  Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X.

Authors:  R J Hagerman; M Leehey; W Heinrichs; F Tassone; R Wilson; J Hills; J Grigsby; B Gage; P J Hagerman
Journal:  Neurology       Date:  2001-07-10       Impact factor: 9.910

3.  Transcript levels of the intermediate size or grey zone fragile X mental retardation 1 alleles are raised, and correlate with the number of CGG repeats.

Authors:  Danuta Z Loesch; Quang M Bui; Richard M Huggins; Robert J Mitchell; Randi J Hagerman; Flora Tassone
Journal:  J Med Genet       Date:  2006-08-11       Impact factor: 6.318

4.  The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group.

Authors:  C Kamm; D G Healy; N P Quinn; U Wüllner; J C Moller; L Schols; F Geser; K Burk; A D Børglum; M T Pellecchia; E Tolosa; F del Sorbo; C Nilsson; O Bandmann; M Sharma; P Mayer; M Gasteiger; A Haworth; T Ozawa; A J Lees; J Short; P Giunti; E Holinski-Feder; T Illig; H E Wichmann; G K Wenning; N W Wood; T Gasser
Journal:  Brain       Date:  2005-06-09       Impact factor: 13.501

5.  Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS).

Authors:  J S Adams; P E Adams; D Nguyen; J A Brunberg; F Tassone; W Zhang; K Koldewyn; S M Rivera; J Grigsby; L Zhang; C DeCarli; P J Hagerman; R J Hagerman
Journal:  Neurology       Date:  2007-08-28       Impact factor: 9.910

6.  Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation.

Authors:  R J Hagerman; B R Leavitt; F Farzin; S Jacquemont; C M Greco; J A Brunberg; F Tassone; D Hessl; S W Harris; L Zhang; T Jardini; L W Gane; J Ferranti; L Ruiz; M A Leehey; J Grigsby; P J Hagerman
Journal:  Am J Hum Genet       Date:  2004-04-02       Impact factor: 11.025

7.  Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates.

Authors:  Sébastien Jacquemont; Randi J Hagerman; Maureen Leehey; Jim Grigsby; Lin Zhang; James A Brunberg; Claudia Greco; Vincent Des Portes; Tristan Jardini; Richard Levine; Elizabeth Berry-Kravis; W Ted Brown; Stephane Schaeffer; John Kissel; Flora Tassone; Paul J Hagerman
Journal:  Am J Hum Genet       Date:  2003-03-12       Impact factor: 11.025

Review 8.  Molecular pathogenesis of fragile X-associated tremor/ataxia syndrome.

Authors:  Christopher Raske; Paul J Hagerman
Journal:  J Investig Med       Date:  2009-12       Impact factor: 2.895

9.  Small CGG repeat expansion alleles of FMR1 gene are associated with parkinsonism.

Authors:  D Z Loesch; M S Khaniani; H R Slater; J P Rubio; Q M Bui; K Kotschet; W D'Souza; A Venn; P Kalitsis; A K H Choo; T Burgess; L Johnson; A Evans; M Horne
Journal:  Clin Genet       Date:  2009-09-30       Impact factor: 4.438

10.  Evidence for the toxicity of bidirectional transcripts and mitochondrial dysfunction in blood associated with small CGG expansions in the FMR1 gene in patients with parkinsonism.

Authors:  Danuta Z Loesch; David E Godler; Andrew Evans; Quang M Bui; Freya Gehling; Katya E Kotschet; Nicholas Trost; Elsdon Storey; Paige Stimpson; Glynda Kinsella; David Francis; David R Thorburn; Alison Venn; Howard R Slater; Malcolm Horne
Journal:  Genet Med       Date:  2011-05       Impact factor: 8.822

View more
  30 in total

1.  Immune mediated disorders in women with a fragile X expansion and FXTAS.

Authors:  Isha Jalnapurkar; Nuva Rafika; Flora Tassone; Randi Hagerman
Journal:  Am J Med Genet A       Date:  2014-11-14       Impact factor: 2.802

Review 2.  Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder.

Authors:  Reymundo Lozano; Veronica Martinez-Cerdeno; Randi J Hagerman
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 3.  Advanced technologies for the molecular diagnosis of fragile X syndrome.

Authors:  Flora Tassone
Journal:  Expert Rev Mol Diagn       Date:  2015-10-21       Impact factor: 5.225

4.  FXTAS in an unmethylated mosaic male with fragile X syndrome from Chile.

Authors:  L Santa María; A Pugin; M A Alliende; S Aliaga; B Curotto; T Aravena; H-T Tang; G Mendoza-Morales; R Hagerman; F Tassone
Journal:  Clin Genet       Date:  2013-10-13       Impact factor: 4.438

Review 5.  General Anesthetic Use in Fragile X Spectrum Disorders.

Authors:  Andrew Ligsay; Marwa El-Deeb; Maria J Salcedo-Arellano; Nina Schloemerkemper; Jeremy S Grayson; Randi Hagerman
Journal:  J Neurosurg Anesthesiol       Date:  2019-07       Impact factor: 3.956

6.  Evidence for the role of FMR1 gray zone alleles as a risk factor for parkinsonism in females.

Authors:  Danuta Z Loesch; Flora Tassone; George D Mellick; Malcolm Horne; Justin P Rubio; Minh Q Bui; David Francis; Elsdon Storey
Journal:  Mov Disord       Date:  2018-07       Impact factor: 10.338

7.  FMR1 Premutation: Basic Mechanisms and Clinical Involvement.

Authors:  Montserrat Milà; Laia Rodriguez-Revenga; Antoni Matilla-Dueñas
Journal:  Cerebellum       Date:  2016-10       Impact factor: 3.847

Review 8.  Fragile X-associated tremor/ataxia syndrome.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Ann N Y Acad Sci       Date:  2015-01-26       Impact factor: 5.691

Review 9.  Fragile X syndrome.

Authors:  Wilmar Saldarriaga; Flora Tassone; Laura Yuriko González-Teshima; Jose Vicente Forero-Forero; Sebastián Ayala-Zapata; Randi Hagerman
Journal:  Colomb Med (Cali)       Date:  2014-12-30

Review 10.  Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management.

Authors:  Randi J Hagerman; Paul Hagerman
Journal:  Nat Rev Neurol       Date:  2016-06-24       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.